Present and Future Treatment Strategies for Pulmonary Arterial Hypertension: Focus on Phosphodiesterase-5 Inhibitors

Author： Kane Laura B.   Klings Elizabeth S.  

Publisher： Adis International

ISSN： 1176-3450

Source： Treatments in Respiratory Medicine, Vol.5, Iss.4, 2006-01, pp. : 271-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Treatment of the Pulmonary Arterial Hypertension

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension: A Comprehensive Review of Pharmacological Treatment

By Erika Berman Rosenzweig   Barst Robyn J.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 2, 2006-01 ,pp. : 117-127

Adis International

Access to resources Recommend Favorite

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension

By Chhina Mantej K   Nargues Weir   Grant Geraldine M   Nathan Steven D  

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 19-35

Future Medicine

Access to resources Recommend Favorite

Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 142-149

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Phosphodiesterase Inhibitors in the Treatment of Chronic Obstructive Pulmonary Disease

By  

Current Respiratory Medicine Reviews, Vol. 13, Iss. 2, 2017-12 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite